SKINRARE: In This Skin Together Community Event
In This Skin Together is bringing together individuals affected by rare and chronic skin conditions, alongside aspiring dermatology professionals, skincare founders, creators, advocates, and anyone interested in learning more about the rare skin disease community.
Hosted through the Creative Futures Collective × Soho House Program and proudly sponsored by Beiersdorf, makers of Aquaphor and Eucerin, Phoilex, Milk & Honey, & Diversity In Dermatology, this evening is designed to foster education, meaningful conversation, networking, and community.
Throughout the evening, you'll experience:
• Patient & Creator Panel – Hear firsthand stories from individuals living with rare and chronic skin conditions as they share their journeys, challenges, and advocacy.
• Dermatology Professionals & Skincare Founders Panel – Gain insights into patient-centered care, emerging innovations in dermatology, and how brands are helping shape a more inclusive future for skincare.
• Community Networking Social Hour – Connect with patients, healthcare professionals, students, founders, creators, and advocates who are passionate about advancing skin health and building community.
As a thank-you for joining us, attendees will receive curated gift bags featuring products from incredible partners, including Elite Wellness‘s complimentary Red Light Therapy session, Sky & Sol, Lemon of the Sun, & additional wellness and skincare brands.
Whether you're navigating life with a skin condition, pursuing a career in dermatology, building the future of skincare, or simply hoping to learn and connect, we welcome you to join us for an evening where every story, perspective, and person belongs.
DOORS OPEN AT 11:30 AM & EVENT STARTS AT 12PM :)
**Please note:** Due to venue capacity, we are able to accommodate up to **50 complimentary non–Soho House member guests**. As part of registration, you'll be asked a few brief questions to help us create a balanced, inclusive experience that reflects the diverse perspectives of the rare and chronic skin disease community. We appreciate your thoughtful responses and look forward to reviewing your submission.